Allows users to produce estimates and MSE for multivariate variables using Linear Mixed Model. The package follows the approach of Datta, Day and Basawa (1999) <doi:10.1016/S0378-3758(98)00147-5>.

66 data sets that were imported using read.table() where appropriate but more commonly after converting to a csv file for importing via read.csv().

Citrus is a computational technique developed for the analysis
    of high dimensional cytometry data sets. This package extracts, statistically
    analyzes, and visualizes marker expression from 'citrus' data. This code was used to 
    generate data for Figures 3 and 4 in the forthcoming manuscript: Throm et al. 
    “Identification of Enhanced Interferon-Gamma Signaling in Polyarticular Juvenile 
    Idiopathic Arthritis with Mass Cytometry”, JCI-Insight. For more information on Citrus,
    please see: Bruggner et al. (2014) <doi:10.1073/pnas.1408792111>. To download
    the 'citrus' package, please see <https://github.com/nolanlab/citrus>.

This is a method (MinED) for mining probability distributions using deterministic sampling which is proposed by Joseph, Wang, Gu, Lv, and Tuo (2019) <DOI:10.1080/00401706.2018.1552203>. The MinED samples can be used for approximating the target distribution. They can be generated from a density function that is known only up to a proportionality constant and thus, it might find applications in Bayesian computation. Moreover, the MinED samples are generated with much fewer evaluations of the density function compared to random sampling-based methods such as MCMC and therefore, this method will be especially useful when the unnormalized posterior is expensive or time consuming to evaluate. This research is supported by a U.S. National Science Foundation grant DMS-1712642.

The nonparametric two-stage Bayesian adaptive design is a novel phase II clinical trial design for finding the minimum effective dose (MinED). This design is motivated by the top priority and concern of clinicians when testing a new drug, which is to effectively treat patients and minimize the chance of exposing them to subtherapeutic or overly toxic doses. It is used to design single-agent trials.